Trial Search Results
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Stanford is currently not accepting patients for this trial.
- Procedure: bone marrow aspiration
- Procedure: peripheral blood sampling
- Children with newly diagnosed T-cell ALL
Ages Eligible for Study
N/A - 18 Years
Genders Eligible for Study